Roivant Sciences
formerly RoivantReinventing the discovery, development, and commercialization of new medicines
New York, United States · Founded 2014 · $1.3B raised
- Headquarters
- New York, New York
- Employees
- 201–500
- Founded
- 2014
- Business Model
- B2B
- Website
- roivant.com
- Total Funding
- $1.3B
- Last Round
- $200.0M Growth EquityNov 2018
- Rounds
- 2
About
Roivant Sciences is a biotech holding company that aims to improve health by rapidly delivering innovative medicines and technologies to patients. It builds agile, focused companies called Vants across multiple therapeutic areas.
Summary
Roivant Sciences is a Biotech company based in New York, United States, founded in 2014. It has raised $1.3B in total across 2 rounds, most recently a $200.0M Growth Equity round in Nov 2018. Investors include SoftBank, NovaQuest and RTW Investments.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2018
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
.png)
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...